Sign in Subscribe
Coronaviruses

UK Covid-19 Vaccination Efforts Show Progress, Concerns Remain

Strategic Insights

— 2 min read

The UK's healthcare workers have made a "colossal" effort in vaccinating over 10 million people against Covid-19, with the number of Covid patients in hospital beginning to fall for the first time since the new wave started. However, the level of infection remains high, with 32,000 Covid patients still in hospital, putting immense pressure on the NHS. Vaccines have been shown to reduce death and serious illness from the main coronavirus strains, but with the emergence of new variants, efforts are being made to develop new vaccines by the autumn.

Key Takeaways:

  • The UK has vaccinated over 10 million people against Covid-19, with a "colossal" effort from healthcare workers.
  • Although hospitalizations are beginning to decrease, the level of infection remains high, with 32,000 Covid patients in hospital.
  • Vaccines have been shown to reduce death and serious illness from the main coronavirus strains.
  • England's chief medical officer, Professor Chris Whitty, states that the number of people in hospital with Covid has decreased, but still exceeds that of the first peak in April 2021.
  • Professor Whitty notes that the number of deaths will "stay high for quite some time."
  • The team behind the Oxford University/AstraZeneca jab has announced plans to develop vaccines against new coronavirus variants, with a goal to have new vaccines available by the autumn.
  • New variants with the E484K mutation could make vaccines less effective, but are still expected to offer good protection against illness and severe disease.
  • Surge-testing is being conducted in eight postcode areas of England where community transmission is feared due to the presence of the South African variant.

Statistics:

  • Over 10 million people have been vaccinated against Covid-19 in the UK.
  • 32,000 Covid patients are still in hospital.
  • The number of people with Covid in hospital has decreased, but still exceeds 10,000 per day.
  • The number of deaths from Covid will "stay high for quite some time."
  • Vaccines are expected to offer good protection against illness and severe disease, even in the presence of the E484K mutation.
  • The Oxford University/AstraZeneca jab team aims to have new vaccines available by the autumn.

Sources:

  • The Prime Minister's speech at the Downing Street press conference.
  • England's chief medical officer, Professor Chris Whitty.
  • Professor Andrew Pollard, director of the Oxford Vaccine Group.
  • Sir Mene Pangalos, executive vice president of biopharmaceuticals research and development at AstraZeneca.
  • Studies conducted by the Oxford University/AstraZeneca jab team on the E484K mutation and its effects on vaccine efficacy.

Read more